Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells

Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv1–21.

CAS  PubMed  Article  Google Scholar 

Eberhardt WE, Stuschke M. Multimodal treatment of non-small-cell lung cancer. Lancet 2015;386:1018–20.

PubMed  Article  Google Scholar 

Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683–92.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Seligson DB, Horvath S, McBrian MA, Mah V, Yu H, Tze S, et al. Global levels of histone modifications predict prognosis in different cancers. Am J Pathol. 2009;174:1619–28.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kurdistani SK. Histone modifications in cancer biology and prognosis. Prog Drug Res. 2011;67:91–106.

CAS  PubMed  Google Scholar 

Barlési F, Giaccone G, Gallegos-Ruiz MI, Loundou A, Span SW, Lefesvre P, et al. Global histone modifications predict prognosis of resected non small-cell lung cancer. J Clin Oncol. 2007;25:4358–64.

PubMed  Article  Google Scholar 

Brzeziańska E, Dutkowska A, Antczak A. The significance of epigenetic alterations in lung carcinogenesis. Mol Biol Rep. 2013;40:309–25.

PubMed  Article  CAS  Google Scholar 

Bajbouj K, Al-Ali A, Ramakrishnan RK, Saber-Ayad M, Hamid Q. Histone modification in NSCLC: molecular mechanisms and therapeutic targets. Int J Mol Sci. 2021;22:11701.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Di Martile M, Del Bufalo D, Trisciuoglio D. The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target. Oncotarget 2016;7:55789–810.

PubMed  PubMed Central  Article  Google Scholar 

Zor T, De Guzman RN, Dyson HJ, Wright PE. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. J Mol Biol. 2004;337:521–34.

CAS  PubMed  Article  Google Scholar 

Ruas JL, Poellinger L, Pereira T. Role of CBP in regulating HIF-1-mediated activation of transcription. J Cell Sci. 2005;118:301–11.

CAS  PubMed  Article  Google Scholar 

Ferreon JC, Lee CW, Arai M, Martinez-Yamout MA, Dyson HJ, Wright PE. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. Proc Natl Acad Sci USA. 2009;106:6591–6.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Xie M, Fu XG, Jiang K. Notch1/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer. Cell Death Dis. 2021;12:832.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gao Y, Geng J, Hong X, Qi J, Teng Y, Yang Y, et al. Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. Int J Clin Exp Pathol. 2014;7:760–7.

PubMed  PubMed Central  Google Scholar 

Aljohani HM, Aittaleb M, Furgason JM, Amaya P, Deeb A, Chalmers JJ, et al. Genetic mutations associated with lung cancer metastasis to the brain. Mutagenesis. 2018;33:137–45.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kim KB, Dunn CT, Park KS. Recent progress in mapping the emerging landscape of the small-cell lung cancer genome. Exp Mol Med. 2019;51:1–13.

PubMed  PubMed Central  Google Scholar 

Chang R, Zhang Y, Zhang P, Zhou Q. Snail acetylation by histone acetyltransferase p300 in lung cancer. Thorac Cancer. 2017;8:131–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tang Z, Yu W, Zhang C, Zhao S, Yu Z, Xiao X, et al. CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway. Mol Oncol. 2016;10:317–29.

CAS  PubMed  Article  Google Scholar 

Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ, et al. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers. Eur J Surg Oncol. 2012;38:523–30.

CAS  PubMed  Article  Google Scholar 

Hou X, Gong R, Zhan J, Zhou T, Ma Y, Zhao Y, et al. p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells. BMC Cancer. 2018;18:641.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Zhang B, Chen D, Liu B, Dekker FJ, Quax WJ. A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL. Biochem Pharm. 2020;175:113914.

CAS  PubMed  Article  Google Scholar 

Strachowska M, Gronkowska K, Michlewska S, Robaszkiewicz A. CBP/p300 bromodomain inhibitor-I-CBP112 declines transcription of the key ABC transporters and sensitizes cancer cells to chemotherapy drugs. Cancers. 2021;13:4614.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ogiwara H, Sasaki M, Mitachi T, Oike T, Higuchi S, Tominaga Y, et al. Targeting p300 addiction in CBP-deficient cancers causes synthetic lethality by apoptotic cell death due to abrogation of MYC expression. Cancer Disco. 2016;6:430–45.

CAS  Article  Google Scholar 

Oike T, Komachi M, Ogiwara H, Amornwichet N, Saitoh Y, Torikai K, et al. C646, a selective small molecule inhibitor of histone acetyltransferase p300, radiosensitizes lung cancer cells by enhancing mitotic catastrophe. Radiother Oncol. 2014;111:222–7.

CAS  PubMed  Article  Google Scholar 

Michaelides MR, Kluge A, Patane M, Van Drie JH, Wang C, Hansen TM, et al. Discovery of spiro oxazolidinediones as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases. ACS Med Chem Lett. 2017;9:28–33.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Lasko LM, Jakob CG, Edalji RP, Qiu W, Montgomery D, Digiammarino EL, et al. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours. Nature. 2017;550:128–32.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Waddell A, Mahmud I, Ding H, Huo Z, Liao D. Pharmacological inhibition of CBP/p300 blocks estrogen receptor alpha (ERα) function through suppressing enhancer H3K27 acetylation in luminal breast cancer. Cancers. 2021;13:2799.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhao YG, Codogno P, Zhang H. Machinery, regulation and pathophysiological implications of autophagosome maturation. Nat Rev Mol Cell Biol. 2021;22:733–50.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bánréti A, Sass M, Graba Y. The emerging role of acetylation in the regulation of autophagy. Autophagy. 2013;9:819–29.

PubMed  PubMed Central  Article  Google Scholar 

Lamb CA, Yoshimori T, Tooze SA. The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol. 2013;14:759–74.

CAS  PubMed  Article  Google Scholar 

Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy. 2021;17:1–382.

PubMed  PubMed Central  Article  Google Scholar 

Wang R, He Y, Robinson V, Yang Z, Hessler P, Lasko LM, et al. Targeting lineage-specific MITF pathway in human melanoma cell lines by A-485, the selective small-molecule inhibitor of p300/CBP. Mol Cancer Ther. 2018;17:2543–50.

CAS  PubMed  Article  Google Scholar 

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–217.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22:377–88.

CAS  PubMed  Article  Google Scholar 

Luo Y, Zou P, Zou J, Wang J, Zhou D, Liu L. Autophagy regulates ROS-induced cellular senescence via p21 in a p38 MAPKα dependent manner. Exp Gerontol. 2011;46:860–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ngoi NY, Liew AQ, Chong SJF, Davids MS, Clement MV, Pervaiz S. The redox-senescence axis and its therapeutic targeting. Redox Biol. 2021;45:102032.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wang F, Liu S, Shen Y, Zhuang R, Xi J, Fang H, et al. Protective effects of N-acetylcysteine on cisplatin-induced oxidative stress and DNA damage in HepG2 cells. Exp Ther Med. 2014;8:1939–45.

CAS  PubMed 

留言 (0)

沒有登入
gif